Unravelling heparin's enhancement of amyloid aggregation in a model peptide system

被引:1
|
作者
Gotla, Suhas [1 ]
Poddar, Anushka [1 ]
Borison, Ilana [1 ]
Matysiak, Silvina [1 ]
机构
[1] Univ Maryland, Fischell Dept Engn, College Pk, MD 20742 USA
关键词
PHYSICOCHEMICAL CHARACTERIZATION; FIBRIL FORMATION; GLYCOSAMINOGLYCANS; MODULATION; ALZHEIMERS; MECHANISM;
D O I
10.1039/d4cp02331e
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A coarse-grained (CG) model for heparin, an anionic polysaccharide, was developed to investigate the mechanisms of heparin's enhancement of fibrillation in many amyloidogenic peptides. CG molecular dynamics simulations revealed that heparin, by forming contacts with the model amyloidogenic peptide, amyloid-beta's K16LVFFAE22 fragment (A beta 16-22), promoted long-lived and highly beta-sheet-like domains in the peptide oligomers. Concomitantly, heparin-A beta 16-22 contacts suppressed the entropy of mixing of the oligomers' beta-domains. Such oligomers could make better seeds for fibrillation, potentially contributing to heparin's fibril-enhancing behaviour. Additionally, reductions in heparin's flexibility led to delayed aggregation, and less ordered A beta 16-22 oligomers, thus offering insights into the contrasting inhibition of fibrillation by the relatively rigid polysaccharide, chitosan. By forming contacts with amyloid-beta oligomers, heparin suppressed the peptides' entropy of mixing and enhanced their parallel ordering.
引用
收藏
页码:22278 / 22285
页数:8
相关论文
共 50 条
  • [31] Prediction of fibril formation by early-stage amyloid peptide aggregation
    Hu, Jiaojiao
    Sun, Huiyong
    Hao, Haiping
    Zheng, Qiuling
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2020, 10 (02) : 194 - 199
  • [32] A Coarse-Grained Model for Peptide Aggregation on a Membrane Surface
    Morriss-Andrews, Alex
    Brown, Frank L. H.
    Shea, Joan-Emma
    JOURNAL OF PHYSICAL CHEMISTRY B, 2014, 118 (28) : 8420 - 8432
  • [33] Multivalent Polymer-Peptide Conjugates: A General Platform for Inhibiting Amyloid Beta Peptide Aggregation
    Jiang, Xing
    Halmes, Abigail J.
    Licari, Giuseppe
    Smith, John W.
    Song, Yang
    Moore, Edwin G.
    Chen, Qian
    Tajkhorshid, Emad
    Rienstra, Chad M.
    Moore, Jeffrey S.
    ACS MACRO LETTERS, 2019, 8 (10) : 1365 - 1371
  • [34] Inhibition of β-amyloid1-40 Peptide Aggregation and Neurotoxicity by Citrate
    Park, Yong Hoon
    Kim, Young-Jin
    Son, Il Hong
    Yang, Hyun Duk
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2009, 13 (04) : 273 - 279
  • [35] Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
    Braun, Gabriel A.
    Dear, Alexander J.
    Sanagavarapu, Kalyani
    Zetterberg, Henrik
    Linse, Sara
    CHEMICAL SCIENCE, 2022, 13 (08) : 2423 - 2439
  • [36] Computational Design of New Peptide Inhibitors for Amyloid Beta (Aβ) Aggregation in Alzheimer's Disease: Application of a Novel Methodology
    Eskici, Gozde
    Gur, Mert
    PLOS ONE, 2013, 8 (06):
  • [37] Modification of a Small β-Barrel Protein, To Give Pseudo-Amyloid Structures, Inhibits Amyloid β-Peptide Aggregation
    Murakoshi, Yuko
    Takahashi, Tsuyoshi
    Mihara, Hisakazu
    CHEMISTRY-A EUROPEAN JOURNAL, 2013, 19 (14) : 4525 - 4531
  • [38] A Peptide-Polyphenol Coated Polypyrrole Nanoparticle for Synergetic Attenuation of Aggregation and Cytotoxicity of Amyloid-β Fibrils
    Zhang, Zhuo
    Lv, Mingchen
    Liu, Yaping
    Qin, Jinlong
    Fan, Zhen
    Du, Jianzhong
    ADVANCED FUNCTIONAL MATERIALS, 2024, 34 (36)
  • [39] A lattice-gas model for amyloid fibril aggregation
    Hong, Liu
    Qi, Xianghong
    Zhang, Yang
    EPL, 2011, 94 (06)
  • [40] Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010-2012)
    Belluti, Federica
    Rampa, Angela
    Gobbi, Silvia
    Bisi, Alessandra
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (05) : 581 - 596